Schrödinger (NASDAQ:SDGR) Hits New 1-Year Low – Should You Sell?

Schrödinger, Inc. (NASDAQ:SDGR)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as $16.60 and last traded at $16.81, with a volume of 122513 shares changing hands. The stock had previously closed at $18.03.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SDGR. Piper Sandler lowered their price objective on Schrödinger from $50.00 to $45.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. KeyCorp boosted their price target on Schrödinger from $25.00 to $27.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $32.29.

Schrödinger Price Performance

The business has a 50-day moving average of $22.74 and a 200 day moving average of $20.75. The company has a market capitalization of $1.29 billion, a PE ratio of -7.63 and a beta of 1.77.

Schrödinger (NASDAQ:SDGR) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $88.32 million for the quarter, compared to analysts’ expectations of $83.20 million. As a group, research analysts anticipate that Schrödinger, Inc. will post -2.37 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the transaction, the chief financial officer now owns 27,544 shares of the company’s stock, valued at approximately $599,357.44. This trade represents a 16.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 8.60% of the company’s stock.

Institutional Investors Weigh In On Schrödinger

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. increased its position in shares of Schrödinger by 4.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 498,513 shares of the company’s stock valued at $9,247,000 after purchasing an additional 19,436 shares during the last quarter. Holocene Advisors LP purchased a new position in Schrödinger during the third quarter worth $239,000. Point72 DIFC Ltd bought a new position in Schrödinger during the third quarter valued at $151,000. Quarry LP raised its stake in shares of Schrödinger by 1,150.0% in the third quarter. Quarry LP now owns 2,825 shares of the company’s stock valued at $52,000 after acquiring an additional 2,599 shares during the period. Finally, Stifel Financial Corp lifted its holdings in shares of Schrödinger by 12.3% in the 3rd quarter. Stifel Financial Corp now owns 27,541 shares of the company’s stock worth $511,000 after acquiring an additional 3,020 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.